GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » Operating Margin %

Avacta Group (Avacta Group) Operating Margin % : -136.86% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Avacta Group Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Avacta Group's Operating Income for the six months ended in Dec. 2023 was $-19.68 Mil. Avacta Group's Revenue for the six months ended in Dec. 2023 was $14.38 Mil. Therefore, Avacta Group's Operating Margin % for the quarter that ended in Dec. 2023 was -136.86%.

Good Sign:

Avacta Group PLC operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Avacta Group's Operating Margin % or its related term are showing as below:

AVCTF' s Operating Margin % Range Over the Past 10 Years
Min: -988.88   Med: -274.91   Max: -69.37
Current: -114.93


AVCTF's Operating Margin % is ranked better than
54.72% of 1027 companies
in the Biotechnology industry
Industry Median: -171.72 vs AVCTF: -114.93

Avacta Group's 5-Year Average Operating Margin % Growth Rate was 14.10% per year.

Avacta Group's Operating Income for the six months ended in Dec. 2023 was $-19.68 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-33.78 Mil.

Warning Sign:

Avacta Group PLC has never been profitable in the past 3 years. It lost money every year.


Avacta Group Operating Margin % Historical Data

The historical data trend for Avacta Group's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Operating Margin % Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -377.48 -867.42 -988.85 -288.20 -114.93

Avacta Group Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,246.07 -163.13 -455.02 -93.98 -136.86

Competitive Comparison of Avacta Group's Operating Margin %

For the Biotechnology subindustry, Avacta Group's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avacta Group's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Avacta Group's Operating Margin % falls into.



Avacta Group Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Avacta Group's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-33.819 / 29.427
=-114.93 %

Avacta Group's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-19.676 / 14.377
=-136.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group  (OTCPK:AVCTF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Avacta Group Operating Margin % Related Terms

Thank you for viewing the detailed overview of Avacta Group's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group (Avacta Group) Business Description

Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group (Avacta Group) Headlines

From GuruFocus

Avacta Selects Second pre|CISION� Pro-drug Candidate for Development

By Business Wire Business Wire 01-18-2022

Avacta Appoints Dr Christina Coughlin as Non-Executive Director

By Business Wire Business Wire 03-21-2022

Avacta Announces Collaboration Agreement With Bruker

By Business Wire Business Wire 01-28-2021

Avacta announces AffyXell $7.3 Million Series A Financing

By Business Wire Business Wire 02-01-2021

Avacta Group plc Signs License Agreement With Astrea Bioseparations

By Business Wire Business Wire 12-21-2020

Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

By Business Wire Business Wire 09-02-2020

LG Chem Renews License Triggering Payment to Avacta

By Business Wire Business Wire 06-30-2022

Avacta Appoints COVID-19 Rapid Antigen Test Manufacturing Partner

By Business Wire Business Wire 08-06-2020

Avacta Announces SARS-CoV-2 Rapid Antigen Test Clinical Collaboration

By Business Wire Business Wire 08-07-2020